Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Particle therapy for prostate cancer: past, present and future.

07/07/2019
/ Publications

A review article by the Japanese researchers about the particle radiotherapy in comparison to photon-based radiation for prostate cancer. Due to a lack of...

Early and late side effects, dosimetric parameters and QoL after PBT and IMRT for prostate cancer

03/03/2019
/ Publications
/
Dosimetry

A study by the researchers of Dresden and Heidelberg. Eighty-eight patients with localized prostate cancer treated with PBT (31) or IMRT (57) were matched using...

Patient-Reported Sexual Survivorship Following High-Dose Image-Guided PT for Prostate Cancer.

03/02/2019
/ Publications
/
Imaging System

A study by the Jacksonville group published in the Green Journal aimed to identify baseline predictive factors that impact long-term erectile function. 676...

Four-year outcomes from a prospective phase II clinical trial of moderately hypofractionated PT for localized prostate cancer.

04/06/2019
/ Publications

Published in the Red Journal, the researchers of Upenn and Groningen reported the clinical and patient-reported outcomes for patients with prostate cancer...

Literature Review of PBT for Prostate Cancer in Japan.

01/01/2019
/ Publications

A literature review on published works related to proton beam therapy for prostate cancer in Japan. 23 articles were analyzed including fourteen observational...

LT results of a phase II study of hypofractionated PT for prostate cancer

01/01/2019
/ Publications

A study by the Korean group of National Cancer Center. Eighty-two patients with T1-3bN0M0 prostate cancer were randomized to one of five arms: Arm 1, 60 cobalt...

Analysis of Gastrointestinal Toxicity in Patients Receiving PBT for Prostate Cancer

08/08/2018
/ Publications
/
Toxicity

A study by the Seattle group. 192 prostate cancer patients were treated with PBT. With the median follow-up of 1.7 years, most of the observed GI toxicity (>90%...

Initial toxicity, QoL outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated vs. standard fractionated PT for low-risk prostate cancer

08/02/2018
/ Publications
/
Hypofractionation
Quality of life

A multi-center prospective phase 3 randomized trial aimed to identify differences in toxicity and quality-of-life outcomes between standard fractionation and...

Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes.

08/09/2018
/ Publications
/
Quality of life

A study by the Seattle group analyzed 231 patients of localized prostate cancer treated with protons. Median follow-up was 1.7 years. Grade 3 toxicity was seen...

Initial report of the genitourinary and gastrointestinal toxicity of post-prostatectomy proton therapy for prostate cancer patients undergoing adjuvant or salvage radiotherapy.

08/07/2018
/ Publications
/
Toxicity

A retrospective analysis on 100 patients' acute and late genitourinary (GU) and gastrointestinal (GI) toxicities associated with post-prostatectomy proton...